
We are building a range of high-quality cannabinoid products that patients and consumers can trust, that are well-characterized and enable dose titration, with the aim of improving options for physicians, patients, and consumers.
We publish our science in peer-reviewed journals and our ambition is to develop innovative products with safe and effective delivery systems for targeted populations and outcomes.
Useful resources
Read the details of our research
We are committed to sharing our science and promoting open, accessible information to build the cannabinoid knowledge base.
Collaborating with the industry
01
We collaborate with other responsible organizations to inform evidence-based frameworks and quality standards for cannabinoid products
We work with industry partners, academic institutions, and regulatory bodies worldwide to improve evidence-based frameworks for cannabinoid product quality, safety, and predictability.
Our team of experts and scientists participates in working groups and committees, such as the ASTM International #D37 Committee on Cannabis.
We believe that robust, science-backed regulations not only protect patients and consumers but also create an environment where responsible innovation can flourish.

Quality
We have end-to-end oversight of all our products, ensuring that high-quality standards at every stage are adopted and met.
From botany to bioavailability, through product purity to stability, to dose control and responsible commercialization. Every step is carefully managed and monitored.